84
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Image-Guided Percutaneous ‎Microwave Ablation Versus Cryoablation For Hepatocellular Carcinoma In High-Risk Locations: Intermediate-Term Results

, , , , &
Pages 9801-9811 | Published online: 18 Nov 2019

References

  • Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127 ):1301–1314. doi:10.1016/S0140-6736(18)30010-229307467
  • Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1 ):9–29. doi:10.3322/caac.2120824399786
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6 ):394–424. doi:10.3322/caac.v68.630207593
  • Piñero F, Poniachik J, Ridruejo E, Silva M. Hepatocellular carcinoma in Latin America: diagnosis and treatment challenges. World J Gastroenterol. 2018;24(37 ):4224–4229. doi:10.3748/wjg.v24.i37.422430310255
  • Ng KK, Cheung TT, Wong TC, et al. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma. Asian J Surg. 2019;42(2 ):433–442. doi:10.1016/j.asjsur.2018.08.00830262437
  • Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29 ):5282–5294. doi:10.3748/wjg.v23.i29.528228839428
  • Medhat E, Abdel AA, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma. J Dig Dis. 2015;16(8 ):456–463. doi:10.1111/1751-2980.1225925958973
  • Han Y, Shao N, Xi X, Hao X. Use of microwave ablation in the treatment of patients with multiple primary malignant tumors. Thorac Cancer. 2017;8(4 ):365–371. doi:10.1111/tca.2017.8.issue-428560833
  • Yu J, Liang P. Status and advancement of microwave ablation in China. Int J Hyperthermia. 2017;33(3):278–287.
  • Littrup PJ, Aoun HD, Adam B, Krycia M, Prus M, Shields A. Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series. Abdom Radiol. 2016;41(4 ):767–780. doi:10.1007/s00261-016-0687-x
  • Hu KQ. Advances in clinical application of cryoablation therapy for hepatocellular carcinoma and metastatic liver tumor. J Clin Gastroenterol. 2014;48(10 ):830–836. doi:10.1097/MCG.000000000000020125148553
  • Rong G, Bai W, Dong Z, et al. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria. PLoS One. 2015;10(4 ):e0123065. doi:10.1371/journal.pone.012306525849963
  • Lo GH. Is cryoablation really more effective than radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2016;63(6 ):2061. doi:10.1002/hep.28005
  • Xu J, Noda C, Erickson A, et al. Radiofrequency ablation vs. cryoablation for localized hepatocellular carcinoma: a propensity-matched population study. Anticancer Res. 2018;38(11 ):6381–6386. doi:10.21873/anticanres.1299730396961
  • Liu CH, Yu CY, Chang WC, et al. Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: evaluation of safety and technical efficacy. J Chin Med Assoc. 2016;79(2 ):93–100. doi:10.1016/j.jcma.2015.07.01326507775
  • Cardella JF, Kundu S, Miller DL, Millward SF, Sacks D. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20(7 Suppl ):S189–S191. doi:10.1016/j.jvir.2009.04.03519559998
  • Ei S, Hibi T, Tanabe M, et al. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox. Ann Surg Oncol. 2015;22(4 ):1294–1300. doi:10.1245/s10434-014-4114-725287439
  • Wang C, Wang H, Yang W, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5 ):1579–1590. doi:10.1002/hep.2754825284802
  • Pusceddu C, Melis L, Ballicu N, et al. Percutaneous microwave ablation under CT guidance for hepatocellular carcinoma: a single institutional experience. J Gastrointest Cancer. 2018;49(3 ):295–301. doi:10.1007/s12029-017-9951-828530021
  • Cui W, Fan W, Huang K, et al. Large hepatocellular carcinomas: treatment with transarterial chemoembolization alone or in combination with percutaneous cryoablation. Int J Hyperthermia. 2018;35(1 ):239–245. doi:10.1080/02656736.2018.149323530200796
  • Filippiadis DK, Gkizas C, Chrysofos M, et al. Percutaneous microwave ablation of renal cell carcinoma using a high power microwave system: focus upon safety and efficacy. Int J Hyperthermia. 2018;34(7 ):1077–1081. doi:10.1080/02656736.2017.140814729202667
  • Gao Y, Wang Y, Duan Y, et al. 915MHz microwave ablation with high output power in in vivo porcine spleens. Eur J Radiol. 2010;75(1 ):87–90. doi:10.1016/j.ejrad.2009.03.00919349134
  • Knavel EM, Hinshaw JL, Lubner MG, et al. High-powered gas-cooled microwave ablation: shaft cooling creates an effective stick function without altering the ablation zone. AJR Am J Roentgenol. 2012;198(3 ):W260–W265. doi:10.2214/AJR.11.650322358023
  • Smolock AR, Lubner MG, Ziemlewicz TJ, et al. Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective. AJR Am J Roentgenol. 2015;204(1 ):197–203. doi:10.2214/AJR.14.1287925539257
  • Zhang H, Fan W, Huang Z, Zhang L, Song Z, Qi H. [Computed tomography-guided percutaneous microwave ablation for diaphragm-abutting liver tumors: assessments of safety and short-term therapeutic efficacies]. Zhonghua Yi Xue Za Zhi. 2014;94(17 ):1313–1317.25142851
  • Zhang D, Xie D, Wei X, et al. Microwave ablation of the liver abutting the stomach: insulating effect of a chitosan-based thermosensitive hydrogel. Int J Hyperthermia. 2014;30(2 ):126–133. doi:10.3109/02656736.2013.87404824528259
  • Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34(6 ):863–869. doi:10.1080/02656736.2017.137072828828899
  • Orlacchio A, Bazzocchi G, Pastorelli D, et al. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc Intervent Radiol. 2008;31(3 ):587–594. doi:10.1007/s00270-008-9293-918236104
  • Hsieh YC, Limquiaco JL, Lin CC, Chen WT, Lin SM. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations. Abdom Radiol. 2019;44(3 ):1141–1151. doi:10.1007/s00261-018-1831-6
  • Kim GM, Won JY, Kim MD, et al. Cryoablation of hepatocellular carcinoma with high-risk for percutaneous ablation: safety and efficacy. Cardiovasc Intervent Radiol. 2016;39(10 ):1447–1454. doi:10.1007/s00270-016-1384-427256103
  • Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol. 2008;190(3 ):W187–W195. doi:10.2214/AJR.07.253718287411
  • Abdo J, Cornell DL, Mittal SK, et al. Immunotherapy plus cryotherapy: potential augmented abscopal effect for advanced cancers. Front Oncol. 2018;8:85–88. doi:10.3389/fonc.2018.0008529644213